BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

Shanghai Moyom’s Aphranel® MagiCCrystal Becomes First NMPA-Approved CaHA Filler in China

Shanghai Moyom Biotechnology's high-profile brand, Aphranel® MagiCCrystal CaHA Filler, has officially obtained Class III Medical Device ...

March 24, 2025 | Regulatory

Menarini Group, Stemline, and VisualDx Join Forces to Boost Early Detection of BPDCN Using AI-Driven Skin Imaging

BPDCN is an aggressive hematologic malignancy with a historically poor prognosis VisualDx is a clinical decision support system used by more than 2,300 ...

March 21, 2025 | News

TPIsoftware & Yuan's General Hospital Transform Healthcare with GenAI Platform

TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digit...

March 20, 2025 | News

Vatech and Pearl Partner to Elevate Dental AI Diagnostics with Seamless Integration

Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology, have announced a collaborative alliance aimed at tra...

March 19, 2025 | News

Lunit Secures Multi-Year AI Partnership with SEHA to Advance Breast Cancer Screening in UAE

Lunit , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced that it has signed a multi-year contract with Abu Dha...

March 19, 2025 | News

Akeso’s Penpulimab Secures NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer

Akeso Inc. (9926.HK) announced that its innovative, self-developed anti-PD-1 monoclonal antibody, penpulimab, has been officially approved by the National ...

March 18, 2025 | News

VISTA Eye Specialist Advances Cataract Surgery in Malaysia with AI and Leading Ophthalmic Technologies

Klinik Pakar Mata VISTA Eye Specialist (VISTA), a well-established name in eye care in Malaysia, continues to improve its cataract surg...

March 17, 2025 | News

Teva Hong Kong Partners with Kerry Pharma to Enhance Medicine Distribution Across Hong Kong, Macau, and the Greater Bay Area

Teva Hong Kong ("Teva"), has announced a strategic partnership with Kerry Pharma, the subsidiary of Kerry Logistics Network Ltd ("KLN"). Leveraging Ke...

March 17, 2025 | News

C2N Diagnostics Secures $10M Investment from Samsung to Expand Alzheimer’s Blood Biomarker Testing

-C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, announced a $...

March 14, 2025 | News

AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia

Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...

March 12, 2025 | News

South Korea’s Lunit AI Proven to Enhance Breast Cancer Detection in Landmark Multicenter Study

Lunit, a global leader in AI-powered cancer diagnostics, has announced groundbreaking results from the world’s first large-scale, multicenter, prospe...

March 11, 2025 | News

Docquity Partners with RSUD Umar Wirahadikusumah Sumedang to Enhance Healthcare with AI-Powered Medical Resource Platform Dx

Dx, Docquity's AI platform which is in ongoing development, will enable physicians at the Sumedang hospital to securely access the latest medical re...

March 07, 2025 | News

Lunit Expands AI-Powered Diagnostics in Saudi Arabia with Second HMG Partnership

Lunit , a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a second agreement with Cloud Solutions, a subs...

March 07, 2025 | News

Health2Sync Secures Over $20M in Series C Funding to Drive Global Expansion and AI-Driven Chronic Disease Management

Health2Sync (H2), a leading digital health company specializing in chronic disease management, today announced it has raised over US$20 million in a Series...

March 05, 2025 | News

Stay Connected